Skip to main content
SpringerLink
Log in

Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew

  • Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

An open trial was conducted in 22 in-patients with classic or definite rheumatoid arthritis (RA) and 17 in-patients with M. Bechterew with the aim to investigate the effect of increasing concentrations of piroxicamin vivo on the platelet aggregation in such patients. In all patients therapy with piroxicam (10 mg/d) was started after with-drawing other non-steroidal antiinflammatory drugs. In 36 cases the daily dose of piroxicam was increased to 20 mg/d and in five cases to 30 mg/d based on clinical judgment. The platelet aggregation in platelet-rich plasma (PRP) caused by epinephrine, ADP (both 5 μM) and collagen (2 μg/ml) was measured at the beginning of the trial and before each dose increase. The results of the trial suggest that a significant positive correlation exists between increasing serum concentrations of piroxicam and the degree of inhibition of platelet aggregation, caused by all three platelet aggregation agonists. This action of piroxicam was most pronounced when epinephrine was used as platelet agonist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G. V. R. Born,Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature194, 927–929 (1962).

    PubMed  Google Scholar 

  2. J. R. O'Brien,Platelet aggregation. J. Clin. Pathol.15, 446–455 (1962).

    Google Scholar 

  3. I. F. Charo, R. D. Feinman and T. C. Detweiler,Interrelations of platelet aggregation and secretion. J. Clin. Invest.60, 866–873 (1977).

    Google Scholar 

  4. D. C. McMillan,Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenalin. Nature211, 140–144 (1966).

    PubMed  Google Scholar 

  5. S. Cronberg, P. Kubisz and J. Caen,Demonstration of a plasmatic cofactor different from fibrinogen necessary for platelet release by ADP and adrenaline. Thromb. Diathes. Haemorrh.24, 409–418 (1970).

    Google Scholar 

  6. J. B. Smith and A. L. Willis,Aspirin selectively inhibits prostaglandin production in human platelets. Nature231, 235–239 (1971).

    PubMed  Google Scholar 

  7. J. R. O'Brien,A comparison of an effect of different anti-inflammatory drugs on platelets. J. Clin. Pathol.23, 522–525 (1970).

    PubMed  Google Scholar 

  8. B. A. McIntyre and R. B. Philip,Effect of three non-steroidal anti-inflammatory agents on platelet, function and prostaglandin synthesis in vitro Thromb. Res.12, 67–77 (1977).

    Article  Google Scholar 

  9. J. J. Kocsis, J. Hernandovic, M. J. Silver, J. B. Smith and C. Ingerman,Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins3, 141–148 (1973).

    Article  PubMed  Google Scholar 

  10. F. E. Preston, S. Whipps, C. A. Jackson, A. J. French, P. J. Wyld and C. J. Stoddard,Inhibition of prostacyclin, and platelet thromboxane A2 after low-dose aspirin. New Engl. J. Med.304, 76–79 (1981).

    PubMed  Google Scholar 

  11. B. J. Gaynor and J. W. Constantine,The effect of piroxicam on platelet aggregation. Experientia35, 797–798 (1979).

    Article  PubMed  Google Scholar 

  12. M. Weintraub, K. Case, B. Kroening and H. B. Bosmann,Effects of piroxicam on platelet aggregation. Clin. Pharmacol. Ther.23, 134–135 (1978).

    Google Scholar 

  13. S. Cronberg, E. Wallmark and I. Söderberg,Effect of platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand. J. Haematol.33, 155–159 (1984).

    PubMed  Google Scholar 

  14. F. C. Arnett, S. M. Edworthy, D. A. Bloch, et al.,The criteria for the classification of rheumatoid arthritis. Arth. Rheum.31, 315–324 (1988).

    Google Scholar 

  15. P. M. Bennet and P. H. N. Wood,Population studies of the rheumatic diseases. Exc. Med. Found., Amsterdam Int. Congr. Ser.148, 456 (1966).

    Google Scholar 

  16. H. Migulla, R. G. Alken and H. Hüller,Mikromethode zur Bestimmung der Piroxicamkonzentration im Serum. Pharmazie43, 866–867 (1988).

    PubMed  Google Scholar 

  17. G. Di Minno, M. J. Silver and S. Murphy,Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood61, 1081–1085 (1983).

    PubMed  Google Scholar 

  18. E. M. Huang and T. C. Detwiler,Characteristics of the synergistic actions of platelet aggregation agonists. Blood57, 685–691 (1981).

    PubMed  Google Scholar 

  19. R. L. Kinlough-Rathbone, M. A. Packham, H.-J. Reimers, J.-P. Cazenave and J. F. Mustard,Mechanisms of platelet shape change, aggregation and release induced by collagen, thrombin or A23,187. J. Lab. Clin. Med.90, 707–719 (1977).

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. R. Koytchev & R. -G. Alken

    Present address: Cooperative Clinical Drug Research and Development, Waldstraße 23-24, D-13403, Berlin, Germany

Authors and Affiliations

  1. Institute of Clinical Pharmacology, Humboldt University, Medical Faculty (Charité), Berlin, Germany

    R. Koytchev & R. -G. Alken

  2. Rheumatological Clinic, Berlin-Buch, Zepernicker Straße, 1, D-13125, Berlin, Germany

    E. Gromnica-Ihle

Authors
  1. R. Koytchev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. -G. Alken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Gromnica-Ihle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koytchev, R., Alken, R.G. & Gromnica-Ihle, E. Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew. Agents and Actions 43, 48–52 (1994). https://doi.org/10.1007/BF02005764

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02005764

Key words

Search

Navigation